Background: Chemicals used in leather tanning, rubber processing, and/or adhesives are the most often-cited culprits in footwear dermatitis. Patch testing patients with suspected shoe dermatitis is essential for diagnosis and management.
T HE PREVALENCE OF SHOE DERMATITIS among patients with contact dermatitis has been estimated at 3.3 to 11.7%. 1, 2 In children, the feet are one of the most common sites for contact dermatitis, and footwear is the second leading cause of contact dermatitis cited. 3 Disparities in the series of allergens tested, different methods of shoe manufacture, environmental factors, and varying social trends in footwear across the globe contribute to the difficulty of accurately characterizing the epidemiology of allergic contact dermatitis (ACD) from shoes.
The main components of shoe construction include uppers/straps, soles, insoles, and heel and toe counters (stiff elements that maintain shoe shape). Adhesives are used to attach these parts together. 4 (For a full review of shoe manufacturing, readers are referred to the excellent chapter ''Shoes'' in Contact Dermatitis. 4 ) Chemicals associated with leather, rubber, and adhesives have long been recognized as potentially sensitizing agents. 5, 6 The most common allergens associated with ACD of the feet vary among studies but are typically those involved in leather or rubber processing. 1, [7] [8] [9] [10] The warm moist environment and occlusion provided by shoes are thought to potentiate the development of ACD. 11 ACD from shoes can be debilitating, and the causative agent may not be obvious. Patch testing patients with suspected shoe ACD is essential for identifying the responsible allergen and for guiding shoe selection. Freeman observed that after a mean of 2.9 years from patch testing, 87.5% of 55 patients with footwear dermatitis had improvement or resolution of their symptoms. 9 Studies evaluating the frequency of allergens associated with dermatitis of the feet have been conducted in Europe, 7, 8, [12] [13] [14] [15] [16] [17] the Middle East, 18, 19 Asia, 2, [20] [21] [22] [23] Australia, 9 and regionally in North 1, 10, [24] [25] [26] and South America. 27 To our knowledge, the frequency of allergens associated specifically with a shoe source has not been investigated broadly in North America. The North American Contact Dermatitis Group (NACDG) has collected aggregated data from patients patch-tested across North America from 1971 to the present. Beginning in 2001, a specific three-digit allergen source was coded for each NACDG standard allergen as well as for other relevant allergens not included on the NACDG standard series. The four goals for this retrospective study were (1) to determine the frequency of allergens associated with a shoe source in NACDG patients with footwear ACD, (2) to compare these results to allergen frequencies from other published studies, (3) to quantify the number of shoe-related reactions that were not identified with the NACDG standard series, and (4) to identify relevant allergens not included on the NACDG standard series, based on data from other published studies.
Materials and Methods
Between January 1, 2001, and December 31, 2004, 10,061 patients were patch-tested with the NACDG standard series of 65 allergens. 28 The allergens (obtained from Chemotechnique Diagnostics, Vellinge, Sweden) included in the standard series from 2001 to 2002 were slightly different from those tested from 2003 to 2004 (Table 1) . 28 Patch-testing methods, relevance of reactions, and final diagnoses were determined according to methods previously reported. 28 Relevance and source codes were linked to specific allergens whereas site codes (up to three codes) and final diagnosis (up to three codes) were linked to patients but not to specific allergens. Information on the source of relevant allergens not included on the NACDG standard series was recorded, but the name of the allergen itself was not recorded. At a central location, all data were manually entered into a computerized database using Access 2003 software (Microsoft Corporation, Redmond, WA) and checked for quality assurance. For this analysis, only those individuals with a shoe source of any allergen (standard or other relevant allergen not on the standard series) were included (Group A). Other sequential subgroups analyzed included those patients with a positive reaction to a NACDG standard allergen attributed to a shoe source (Group B), those with feet as a site of involvement (Group C), those with feet as the primary site of involvement (Group D), and those with a final primary diagnosis of ACD (Group E) ( Fig 1) . For simplicity, this report focuses on the most conservative subgroup (Group E). The number of patients for whom shoes were identified as a source of other relevant allergens not included in the NACDG standard series of patch tests was calculated for each group.
To search the existing literature on allergens associated with shoes and/or foot dermatitis, a PubMed search was conducted with the search terms ''shoe AND allergens,'' ''shoe AND patch test,'' ''shoe AND allergic contact dermatitis,'' ''foot dermatitis AND patch test,'' ''foot dermatitis AND allergens,'' and ''foot AND allergic contact dermatitis,'' with results limited to humans and English. Hand searching was also performed for publications predating PubMed. These studies are summarized in Tables 2 and 3, except for those by Vani and colleagues, 22 Chen and colleagues, 23 and Belsito. 26 Data from the investigation of hand and foot dermatitis by Vani and colleagues were excluded in summary tables because individual allergen frequencies were not reported for foot dermatitis separately from hand dermatitis. 22 Data from Chen and colleagues were excluded from summary tables because that investigation focused on rubber chemicals only. 23 Data from Belsito 26 were not included in summary tables because the patients included in that study were also reported in the study by Shackelford and Belsito, 1 represented in Tables 2 and 3 (Donald Belsito, June 15, 2006) . In the study by Trattner and colleagues, allergen frequencies were reported separately for the shoe and standard series. 18 Some patients reacted to the same allergen in both series, but the exact numbers were not published. To avoid duplicating data points, Tables 2 and  3 include only Trattner and colleagues' results from the shoe series, which included many allergens from the standard series. When only percentages were reported in published studies, we calculated exact numbers; these are identified as ''calculated.'' Pooled prevalence rates of published studies were calculated by adding the number of positive reactions to each allergen (numerator) and dividing this number by the total number of positive reactions related to shoes. Analyses comparing pooled rates and NACDG data were performed with SAS software (Statistical Analysis System, SAS Institute Inc. Cary, NC). Pearson's chi square test was used to compare our results with published studies. Fisher's exact test (two tailed) was used when appropriate. A significance level of 0.05 was used for all analysis. Because this was an exploratory analysis, no adjustments for multiple comparisons were performed. 
Results

Demographics
Of the 10,061 patients who were patch-tested by the NACDG between 2001 and 2004, 213 patients had a shoe source identified as either (1) a source of a positive standard series patch-test allergen or (2) a source of a relevant allergen not included in the NACDG standard series (see Fig 1, Group A). Of these 213 patients, 186 had positive patch-test reactions to a standard series allergen attributed to a shoe source (Group B); 160 patients had feet listed as a site, and 121 of those had feet as the primary site of dermatitis involvement (Groups C and D, respectively). Last, 109 patients had a primary diagnosis of ACD with the feet as the primary site of involvement and a positive patch-test result attributed to a shoe source (Group E). Patients who were eliminated on the basis of site often had hand or scattered generalized dermatitis, which in some cases was related to allergens from a nonshoe source. Demographic data for each of the subgroups are shown in Table 4 . Because results for the following analyses did not differ greatly for Groups B to E, we present data from only the most restrictive subgroup, Group E (n 5 109).
Frequencies of Allergens in the NACDG Standard Series
Allergen frequencies for all subsets of patients with positive NACDG standard series patch-test results were evaluated. Among the 109 patients in Group E, there were 154 positive patch-test results ( Table 5) ; 150 (97.4%) were considered to be of definite (9.7%), probable (33.1%), or possible (54.5%) relevance. Four (2.6%) positive patch-test results were considered to be occupationally relevant. In this group of patients, p-tertiary butylphenol formaldehyde resin was the most frequent allergen, followed by potassium dichromate.
Literature Review
Data from past studies on allergens associated with suspected foot and/or footwear dermatitis are summarized in Tables 2 and 3. Table 2 includes (1) allergens that were also on the NACDG standard series, (2) pooled data for these allergens, and (3) the NACDG results for comparison. Table 3 lists relevant allergens from other studies and that were not on the NACDG standard series. Topical medications, ointments, and creams that have been reported to cause foot dermatitis were excluded from these tables.
Comparison of Allergen Frequencies
p-tertiary Butylphenol Formaldehyde Resin p-tertiary Butylphenol formaldehyde resin (PTBFR) has been used as an additive in rubber glues since the 1950s. 29 Currently it is found as a component of neoprene adhesives used to attach shoe linings and insoles. 30 In this study, PTBFR accounted for 24.7% of positive patch-test results related to shoes. In the study of 119 patients with suspected shoe dermatitis in Pakistan by Rani and colleagues, PTBFR was also the most frequent allergen, accounting for 21.6% of positive reactions. 19 This was also the case in the Portuguese study by Correia and Brandão, who found that 23.1% of 539 patients with suspected footwear and/or stocking dermatitis were patch test positive to PTBFR. 15 In contrast, the studies from Kansas, 1 Canada, 10 Brazil, 27 and Britain 7 of patients with suspected footwear dermatitis found PTBFR to represent only up to 4.4% of relevant shoe-related allergens. It is unclear why studies occurring largely over similar time periods and geographic regions have found such varying rates of allergy to PTBFR. However, the inclusion criteria for these studies varied, and this may have affected allergen frequencies. Some studies selected patients on the basis of suspected footwear dermatitis. 10, 15, 19 whereas others included all patients with dermatitis of the feet. 17, 27 When data from published studies were pooled, PTBFR represented 17.1% of positive reactions. NACDG patients were 1.44 times more likely than patients in past studies to have a positive reaction to PTBFR (95% confidence interval [CI], 1.08-1.93; p 5 .0174).
Potassium Dichromate
Chromium salts are used to tan leather. Although trivalent salts are typically used for tanning, hexavalent potassium dichromate is considered more reliable for patch testing. 11 An increased risk of foot dermatitis has been reported in patients with positive reactions to both trivalent and hexavalent salts as compared to patients with negative reactions to trivalent and positive reactions to hexavalent salts. 31 In this study of NACDG patients, only hexavalent potassium dichromate was tested and was found to be the second most frequent shoe-related allergen, accounting for 17.5% of positive reactions. European, 7, 8, 13, 17 Mediterranean, 18 and Indian 2,21 studies of patients with foot dermatitis found potassium dichromate to be the most frequent allergen, accounting for 10.0 to 43.0% of relevant positive reactions. When the data from published studies were pooled, potassium dichromate was the most frequent individual allergen, accounting for 31.5% of reactions. Patients in past studies were 1.80 times more likely than NACDG patients to have a positive reaction to potassium dichromate (95% CI, 1.27-2.54; p 5 .0003).
Rubber Additives
Although an individual rubber component was not the most frequent allergen in this NACDG study, rubber chemicals were the most frequent allergens when considered as a group including carba mix, thiuram mix, mercaptobenzothiazole (MBT), mercapto mix, mixed dialkyl thioureas, and black rubber mix. This finding is consistent with those of the other North American studies of foot dermatitis, 1,10 as well as those of investigations in Brazil, 27 Australia, 9 and Britain, 12 which have found rubber chemicals to be the most common shoe allergen category overall. This is consistent with pooled data from published studies. This trend was noted by Cronin, who documented a shift from leather to rubber as the most common shoe antigen group in Britain in the 1950s and 1960s. 6 Although pooled data demonstrated rubber allergens to be most common as a group, individual allergen frequencies differed. Reactions to carba mix, thiuram mix, and mixed dialkyl thioureas were significantly higher in our NACDG population (p 5 .0001, .0207, and .0080, respectively) whereas reactions to mercapto mix were significantly higher in pooled data (p 5 .0281). Reactions to MBT and black rubber mix were also more frequent in pooled data; however, this difference was not significant (p 5 .1691, and .4531, respectively).
Relevant Allergens Not on the NACDG Standard Series
The numbers of patients with shoes listed as a relevant source of allergens not included on the NACDG standard series for the data subsets are listed in Table 6 . For patients for whom shoes were considered a relevant source of allergens (Group A), the NACDG standard series did not identify the specific shoe allergen in 12.7% of cases and was unable to identify all relevant shoe allergens in 24.9% of cases.
Allergens not on the NACDG standard series that were found to be relevant in other studies are summarized in Table 3 . In one American investigation of foot dermatitis, dithiodimorpholine (DTDM), a rubber accelerator, was responsible for the largest proportion of relevant positive reactions, 1 and this point was highlighted by Belsito. 26 For this reason, DTDM was included in the 2005-2006 NACDG standard series. The NACDG standard series also contains few dyes; 4-aminoazobenzene, Disperse Orange 3, Disperse Yellow 3, and Disperse Red 1 were all responsible for a number of allergic reactions in other studies. 2, 7, 8, 10, 15, 18, 19 Dodecylmercaptan, an adhesive, accounted for 1.4 to 4.8% of relevant positive reactions in four studies of suspected footwear dermatitis. 2, 8, 10, 19 Diphenylthiourea, an accelerator used in the manufacture of neoprene, caused four positive reactions in the study by Trattner and colleagues. 18 This allergen is not included in the dialkyl thiourea mix. On the basis of differences in structure, it is felt that there is little crossreactivity between thioureas, 32 and in Trattner and colleagues' study, at least two patients reacted to diphenylthiourea but not to the dialkyl thiourea mix. Hydroquinone monobenzylether, benzoyl peroxide, 2thiocyanomethyl benzothiazole, 2n-octyl-4-isothiazolin-3-one, Desmocoll 400 (Bayer MaterialScience, Leverkusen, Germany), and Desmodur R (Bayer MaterialScience) each accounted for eight or more positive relevant patch-test results in pooled data from other studies. 1, 2, 7, 8, 10, 12, 18, 19 There are also numerous published reports of reactions to samples of patients' own shoes. 2, 9, 14, 16, 17, 20, 21, 24, 25 
Discussion
In this retrospective analysis of NACDG data, shoe dermatitis affected men (50.5%) and women (49.5%) approximately equally and most commonly was not occupation related. PTBFR was the most frequent individual allergen, followed (in order) by potassium dichromate, carba mix, thiuram mix, colophony, MBT, mercapto mix, mixed dialkyl thioureas, p-phenylenediamine (PPD), and black rubber mix. Nickel sulfate, cobalt chloride, glutaraldehyde, formaldehyde, epoxy resin, and Disperse Blue 106 each accounted for two or fewer positive reactions. When the data were examined according to groups of allergens, rubber additives were most frequent (40.4%), followed by adhesives (32.5%) and leather components (20.1%). To our knowledge, this is the first study using aggregated patch-test data to explore the frequency of allergens identified as having a shoe source in North America.
NACDG patients in this study were statistically more likely to have a positive patch-test reaction to PTBFR, carba mix, thiuram mix, PPD, or black rubber mix and statistically less likely to have a positive patch-test reaction to potassium dichromate, mercapto mix, nickel sulfate, cobalt chloride, or ethylenediamine as compared to pooled data from past studies. There are several possible explanations for these differences. Shoe manufacturing processes and materials change over time and vary around the world. Different environments require appropriate footwear choices, and fashion trends can change quickly. Just as important as these factors is that the series of allergens tested among studies are not consistent and that many standard series may lack important relevant shoe allergens. Therefore, it is possible that these differences are due to variations in study design rather than definitive trends.
In 12.7% of patients, the NACDG standard series failed to identify any relevant allergens. This is consistent with the study by Freeman, who found that 14.5% of 55 patients reacted to samples of their own shoes but did not react to any tested shoe allergens in her series. 9 33, 34 Therefore, PPD may identify allergy to many dyes not on the standard NACDG tray. Evidence for cross-reactivity between PPD and other red, blue, and brown dyes is less compelling. 34 Also, allergy to dodecylmercaptan and possibly to diphenylthiourea may be missed by the current NACDG standard series.
When patch-testing for allergic reactions to shoes, it is common to patch-test with samples of patients' own footwear. However, it is important to recognize that shoe samples must be very thin to avoid pressure effects and false-positive results. 4 Samples should also be first soaked in water for 15 minutes before application 35 and left in place for 4 to 5 days to avoid false-negative results. 4, 11 Finally, one must be assured that tinea pedis has been ruled out since it has been reported that testing with shoe samples can result in a false-positive patch-test reaction due to the transmission of a fungal infection. 36 Podmore compiled an extensive list of potential shoe allergens 30 but concluded that the common allergens causing shoe ACD were already included in the standard series and did not recommend the inclusion of any other allergens in the standard series for the detection of shoe allergens (Patricia Podmore, personal communication [abstract presentation, 44th American Academy of Dermatology Annual Meeting], December 1985). Given the current understanding of the chemicals used to manufacture shoes, it would be impossible to include every potential shoe allergen on a standard series. When using a limited standard series such as the T.R.U.E. Test allergen system (Allerderm, Phoenix, AZ) series, the use of an additional shoe series may be helpful in patients with suspected footwear dermatitis. In circumstances in which the NACDG standard series fails to identify a relevant shoe allergen and footwear dermatitis is strongly suspected, testing with additional dyes, dodecyl mercaptan, other allergens from a shoe series, and/or samples of the patient's own shoes may aid in diagnosis.
This study has several limitations. First, the NACDG does not code the specific allergen name for other relevant allergens not in the standard series. Therefore we were only able to determine that there was a shoe source in these cases. Second, we were unable to determine whether these other relevant allergens came from other patch-test series (such as a supplemental shoe series) or from testing with pieces of the patient's own shoes. Third, the duration of follow-up for determination of relevance to a shoe source is not recorded, and the relevance is not always confirmed over time. Fourth, our data may not be directly comparable to those of other studies. Most published studies included patients on the basis of suspected foot and/or footwear dermatitis whereas our patient data were based on shoes coded as the allergen source. Therefore, other studies were probably more likely to find topical medications and other nonshoe allergens as relevant, decreasing the percentage of positive results attributed to structural shoe source allergens such as rubber, leather, or adhesive chemicals. We attempted to adjust for this by limiting statistical comparisons to only those allergens contained on the NACDG standard series.
Future studies of footwear dermatitis would be greatly enhanced by more complete chemical information from manufacturers. Because of globalization of markets, information on shoe allergens is almost always unavailable. Without this information, identification of new and emerging allergens is extremely complicated and management for patients is difficult. While some information on shoes is available (eg, from ,www.contactderm.org/ members/FootDermatitis.pdf., available to members of the American Contact Dermatitis Society), 37 many sensitized patients must resort to plastic shoes (that lack any leather or rubber allergens) or expensive custom-made shoes. ACD from footwear is a constantly evolving problem and a challenge to both physicians and patients.
